-
3E04 Central Vein
-
3E040 Open
-
3E0400 Antineoplastic
-
3E04002Introduction of High-dose Interleukin-2 into Central Vein, Open Approach
-
3E04003Introduction of Low-dose Interleukin-2 into Central Vein, Open Approach
-
3E04005Introduction of Other Antineoplastic into Central Vein, Open Approach
-
3E0400MIntroduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach
-
3E0400PIntroduction of Clofarabine into Central Vein, Open Approach
-
-
3E0401 Thrombolytic
-
3E0402 Anti-infective
-
3E0403 Anti-inflammatory
-
3E0403ZIntroduction of Anti-inflammatory into Central Vein, Open Approach
-
-
3E0404 Serum, Toxoid and Vaccine
-
3E0404ZIntroduction of Serum, Toxoid and Vaccine into Central Vein, Open Approach
-
-
3E0405 Adhesion Barrier
-
3E0406 Nutritional Substance
-
3E0406ZIntroduction of Nutritional Substance into Central Vein, Open Approach
-
-
3E0407 Electrolytic and Water Balance Substance
-
3E0407ZIntroduction of Electrolytic and Water Balance Substance into Central Vein, Open Approach
-
-
3E040A Stem Cells, Embryonic
-
3E040B Anesthetic Agent
-
3E040E Stem Cells, Somatic
-
3E040F Intracirculatory Anesthetic
-
3E040FZIntroduction of Intracirculatory Anesthetic into Central Vein, Open Approach
-
-
3E040G Other Therapeutic Substance
-
3E040H Radioactive Substance
-
3E040HZIntroduction of Radioactive Substance into Central Vein, Open Approach
-
-
3E040K Other Diagnostic Substance
-
3E040KZIntroduction of Other Diagnostic Substance into Central Vein, Open Approach
-
-
3E040L Sperm
-
3E040M Pigment
-
3E040N Analgesics, Hypnotics, Sedatives
-
3E040NZIntroduction of Analgesics, Hypnotics, Sedatives into Central Vein, Open Approach
-
-
3E040P Platelet Inhibitor
-
3E040PZIntroduction of Platelet Inhibitor into Central Vein, Open Approach
-
-
3E040Q Fertilized Ovum
-
3E040R Antiarrhythmic
-
3E040RZIntroduction of Antiarrhythmic into Central Vein, Open Approach
-
-
3E040S Gas
-
3E040T Destructive Agent
-
3E040TZIntroduction of Destructive Agent into Central Vein, Open Approach
-
-
3E040U Pancreatic Islet Cells
-
3E040V Hormone
-
3E040W Immunotherapeutic
-
3E040X Vasopressor
-
3E040XZIntroduction of Vasopressor into Central Vein, Open Approach
-
-
-
3E043 Percutaneous
-
3E0430 Antineoplastic
-
3E04302Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach
-
3E04303Introduction of Low-dose Interleukin-2 into Central Vein, Percutaneous Approach
-
3E04305Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach
-
3E0430MIntroduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach
-
3E0430PIntroduction of Clofarabine into Central Vein, Percutaneous Approach
-
-
3E0431 Thrombolytic
-
3E0432 Anti-infective
-
3E0433 Anti-inflammatory
-
3E0433ZIntroduction of Anti-inflammatory into Central Vein, Percutaneous Approach
-
-
3E0434 Serum, Toxoid and Vaccine
-
3E0434ZIntroduction of Serum, Toxoid and Vaccine into Central Vein, Percutaneous Approach
-
-
3E0435 Adhesion Barrier
-
3E0436 Nutritional Substance
-
3E0436ZIntroduction of Nutritional Substance into Central Vein, Percutaneous Approach
-
-
3E0437 Electrolytic and Water Balance Substance
-
3E0437ZIntroduction of Electrolytic and Water Balance Substance into Central Vein, Percutaneous Approach
-
-
3E043A Stem Cells, Embryonic
-
3E043B Anesthetic Agent
-
3E043E Stem Cells, Somatic
-
3E043F Intracirculatory Anesthetic
-
3E043FZIntroduction of Intracirculatory Anesthetic into Central Vein, Percutaneous Approach
-
-
3E043G Other Therapeutic Substance
-
3E043GCIntroduction of Other Therapeutic Substance into Central Vein, Percutaneous Approach
-
3E043GNIntroduction of Blood Brain Barrier Disruption Substance into Central Vein, Percutaneous Approach
-
3E043GQIntroduction of Glucarpidase into Central Vein, Percutaneous Approach
-
3E043GRIntroduction of Other Therapeutic Monoclonal Antibody into Central Vein, Percutaneous Approach
-
-
3E043H Radioactive Substance
-
3E043HZIntroduction of Radioactive Substance into Central Vein, Percutaneous Approach
-
-
3E043K Other Diagnostic Substance
-
3E043KZIntroduction of Other Diagnostic Substance into Central Vein, Percutaneous Approach
-
-
3E043L Sperm
-
3E043M Pigment
-
3E043N Analgesics, Hypnotics, Sedatives
-
3E043NZIntroduction of Analgesics, Hypnotics, Sedatives into Central Vein, Percutaneous Approach
-
-
3E043P Platelet Inhibitor
-
3E043PZIntroduction of Platelet Inhibitor into Central Vein, Percutaneous Approach
-
-
3E043Q Fertilized Ovum
-
3E043R Antiarrhythmic
-
3E043RZIntroduction of Antiarrhythmic into Central Vein, Percutaneous Approach
-
-
3E043S Gas
-
3E043T Destructive Agent
-
3E043TZIntroduction of Destructive Agent into Central Vein, Percutaneous Approach
-
-
3E043U Pancreatic Islet Cells
-
3E043V Hormone
-
3E043W Immunotherapeutic
-
3E043X Vasopressor
-
3E043XZIntroduction of Vasopressor into Central Vein, Percutaneous Approach
-
-
-
3E044 Percutaneous Endoscopic
-
3E0440 Antineoplastic
-
3E0441 Thrombolytic
-
3E0442 Anti-infective
-
3E0443 Anti-inflammatory
-
3E0444 Serum, Toxoid and Vaccine
-
3E0445 Adhesion Barrier
-
3E0446 Nutritional Substance
-
3E0447 Electrolytic and Water Balance Substance
-
3E044A Stem Cells, Embryonic
-
3E044B Anesthetic Agent
-
3E044E Stem Cells, Somatic
-
3E044F Intracirculatory Anesthetic
-
3E044G Other Therapeutic Substance
-
3E044H Radioactive Substance
-
3E044K Other Diagnostic Substance
-
3E044L Sperm
-
3E044M Pigment
-
3E044N Analgesics, Hypnotics, Sedatives
-
3E044P Platelet Inhibitor
-
3E044Q Fertilized Ovum
-
3E044R Antiarrhythmic
-
3E044S Gas
-
3E044T Destructive Agent
-
3E044U Pancreatic Islet Cells
-
3E044V Hormone
-
3E044W Immunotherapeutic
-
3E044X Vasopressor
-
-
3E047 Via Natural or Artificial Opening
-
3E0470 Antineoplastic
-
3E0471 Thrombolytic
-
3E0472 Anti-infective
-
3E0473 Anti-inflammatory
-
3E0474 Serum, Toxoid and Vaccine
-
3E0475 Adhesion Barrier
-
3E0476 Nutritional Substance
-
3E0477 Electrolytic and Water Balance Substance
-
3E047A Stem Cells, Embryonic
-
3E047B Anesthetic Agent
-
3E047E Stem Cells, Somatic
-
3E047F Intracirculatory Anesthetic
-
3E047G Other Therapeutic Substance
-
3E047H Radioactive Substance
-
3E047K Other Diagnostic Substance
-
3E047L Sperm
-
3E047M Pigment
-
3E047N Analgesics, Hypnotics, Sedatives
-
3E047P Platelet Inhibitor
-
3E047Q Fertilized Ovum
-
3E047R Antiarrhythmic
-
3E047S Gas
-
3E047T Destructive Agent
-
3E047U Pancreatic Islet Cells
-
3E047V Hormone
-
3E047W Immunotherapeutic
-
3E047X Vasopressor
-
-
3E048 Via Natural or Artificial Opening Endoscopic
-
3E0480 Antineoplastic
-
3E0481 Thrombolytic
-
3E0482 Anti-infective
-
3E0483 Anti-inflammatory
-
3E0484 Serum, Toxoid and Vaccine
-
3E0485 Adhesion Barrier
-
3E0486 Nutritional Substance
-
3E0487 Electrolytic and Water Balance Substance
-
3E048A Stem Cells, Embryonic
-
3E048B Anesthetic Agent
-
3E048E Stem Cells, Somatic
-
3E048F Intracirculatory Anesthetic
-
3E048G Other Therapeutic Substance
-
3E048H Radioactive Substance
-
3E048K Other Diagnostic Substance
-
3E048L Sperm
-
3E048M Pigment
-
3E048N Analgesics, Hypnotics, Sedatives
-
3E048P Platelet Inhibitor
-
3E048Q Fertilized Ovum
-
3E048R Antiarrhythmic
-
3E048S Gas
-
3E048T Destructive Agent
-
3E048U Pancreatic Islet Cells
-
3E048V Hormone
-
3E048W Immunotherapeutic
-
3E048X Vasopressor
-
-
3E04X External
-
3E04X0 Antineoplastic
-
3E04X1 Thrombolytic
-
3E04X2 Anti-infective
-
3E04X3 Anti-inflammatory
-
3E04X4 Serum, Toxoid and Vaccine
-
3E04X5 Adhesion Barrier
-
3E04X6 Nutritional Substance
-
3E04X7 Electrolytic and Water Balance Substance
-
3E04XA Stem Cells, Embryonic
-
3E04XB Anesthetic Agent
-
3E04XE Stem Cells, Somatic
-
3E04XF Intracirculatory Anesthetic
-
3E04XG Other Therapeutic Substance
-
3E04XH Radioactive Substance
-
3E04XK Other Diagnostic Substance
-
3E04XL Sperm
-
3E04XM Pigment
-
3E04XN Analgesics, Hypnotics, Sedatives
-
3E04XP Platelet Inhibitor
-
3E04XQ Fertilized Ovum
-
3E04XR Antiarrhythmic
-
3E04XS Gas
-
3E04XT Destructive Agent
-
3E04XU Pancreatic Islet Cells
-
3E04XV Hormone
-
3E04XW Immunotherapeutic
-
3E04XX Vasopressor
-
-